Table 4.
Expression of AIM2 was negatively correlated with various pathological types of HBV-GN
| |
|
AIM2 |
|
|
||
|---|---|---|---|---|---|---|
| Pathological type | n(%) | - | + | ++ | X 2 | p |
| MsPGN |
15(27.8) |
3 |
8 |
4 |
|
|
| MPGN |
9(16.7) |
1 |
5 |
3 |
|
|
| MN |
27(50.0) |
6 |
11 |
10 |
|
|
| MCG |
1(1.8) |
0 |
1 |
0 |
|
|
| FSS |
2(3.7) |
0 |
1 |
1 |
|
|
| Total | 54 | 10 | 26 | 18 | 2.905 | 0.940 |
MsPGN, Mesangioproliferative glomerulonephritis; MPGN, Membranoproliferative glomerulonephritis; MN, Membranous nephropathy; MCG, Minimal change glomerulopathy; FSS, Focal segmental sclerosis.